专利检索 ap:("MERCK & CO., INC.") AND inv:"BEERE, Polly, A." 第 1 页

1.

发明公开
USE OF ANGIOTENSIN II ANTAGONISTS TO TREAT SYMPTOMATIC HEART FAILURE 失效
标题翻译：血管紧张素Ⅱ拮抗剂心力衰竭症状的治疗

公开(公告)号：EP0966282A1

公开(公告)日：1999-12-29

申请号：EP98903447.0

申请日：1998-01-07

申请人： MERCK & CO., INC.

发明人： BEERE, Polly, A. , CHANG, Paul, I. , PITT, Bertram , RUCINSKA, Ewa, J. , SEGAL, Robert , SHARMA, Divakar , SNAVELY, Duane, B.

IPC分类号： C07D401 , A61K31 , A61K38 , A61K45 , A61P9 , C07D207 , C07D403 , C07D405 , C07D409

CPC分类号： A61K38/04 , A61K31/41 , A61K31/4174 , A61K31/4178 , A61K31/4184 , A61K31/4439 , A61K31/4709 , A61K31/506 , A61K31/519

摘要： Angiotensin II receptor antagonists are useful in reducing and preventing mortality and sudden cardiac death in symptomatic heart failure patients. Losartan potassium has been shown to reduce mortality and sudden cardiac death in this patient population. Additionally, losartan potassium has been shown to reduce the need for hospitalization of symptomatic heart failure patients.

2.

发明授权
USE OF THE ANGIOTENSIN II ANTAGONISTS LOSARTAN AND EXP-3174 TO TREAT SYMPTOMATIC HEART FAILURE 失效
标题翻译：血管紧张素II受体拮抗剂使用氯沙坦和EXP-3174用于治疗症状性心力衰竭

公开(公告)号：EP0966282B1

公开(公告)日：2003-06-25

申请号：EP98903447.5

申请日：1998-01-07

申请人： MERCK & CO., INC.

发明人： BEERE, Polly, A. , CHANG, Paul, I. , PITT, Bertram , RUCINSKA, Ewa, J. , SEGAL, Robert , SHARMA, Divakar , SNAVELY, Duane, B.

IPC分类号： A61K31/41 , A61K31/415 , A61K31/44 , A61K31/47 , A61K31/505 , A61K38/04 , A61P9/00 , A61P9/04

CPC分类号： A61K38/04 , A61K31/41 , A61K31/4174 , A61K31/4178 , A61K31/4184 , A61K31/4439 , A61K31/4709 , A61K31/506 , A61K31/519

摘要： Angiotensin II receptor antagonists are useful in reducing and preventing mortality and sudden cardiac death in symptomatic heart failure patients. Losartan potassium has been shown to reduce mortality and sudden cardiac death in this patient population. Additionally, losartan potassium has been shown to reduce the need for hospitalization of symptomatic heart failure patients.